| UPSA Switzerland AG - Dafalgan i.v. 1 g, Infusionslösung |
| 66702 | | 01 | | Dafalgan i.v. 1 g | | Infusionslösung | | N02BE01 | | Paracetamol | | 30.11.2017 | | |
|
| Composition |
| paracetamolum 1 g, hydroxypropylbetadexum 300 mg, dinatrii edetas, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, aqua ad iniectabile ad solutionem pro 100 ml corresp. natrium 247 mg. |
| Packungsbestandteile |
| Solution pour perfusion | | | | | | Principe actif | Concentr. |
|---|
| Paracetamole | 1g / 100ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Dinatrii Edetas | | | Disodium Phosphate Dihydrate | | | Hydroxypropylbetadexum | 300mg / 100ml | | Sodium Chlorure | | | Sodium Dihydrogenophosphate Dihydrate | |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 10 | | | B | | Non |
|
